Establishment Labs (ESTA) | Stock Overview & Key Data
Establishment Labs Performance Comparison
Stock Range
Today's Range
Low: $38.41
High: $40.59
on August 21, 2025
52 Week Range
Low: $26.56
High: $50.85
on April 9, 2025
on November 7, 2024
All-Time High: $93.80 on April 18, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.1B
EPS
-3.08
P/E Ratio (TTM)
-12.57
Forward P/E
-22.85
P/B Ratio
47.96
PEG Ratio
1.56
Div. Yield
N/A
ROE
-261.18%
Beta
0.829
Debt to Equity
993.34
Financial Highlights
Profitability
Gross Margin
68.76%
Operating Margin
-27.50%
Profit Margin
-49.89%
Returns and Earnings
Return on Assets (TTM)
-12.78%
Return on Equity (TTM)
-261.18%
EBITDA
$-54.0M
Net Income (TTM)
$-88.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$6.16
Quarterly Revenue Growth (YoY)
16.30%
Quarterly Earnings Growth (YoY)
16.28%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Establishment Labs ESTA | 1.09B Small-cap | 5.40% | -6.10% | 11.48% | 19.65% | -11.66% | -12.38% | -38.76% | 127.27% |
| Abbott Laboratories ABT | 229.31B Mega-cap | 2.10% | 6.09% | -0.79% | -2.16% | 16.36% | 17.14% | 29.54% | 19.14% |
| Boston Scientific BSX | 153.73B Large-cap | 1.02% | 1.38% | 0.54% | 0.69% | 17.71% | 32.89% | 159.65% | 156.42% |
| QuidelOrtho QDEL | 1.78B Small-cap | -1.12% | 1.42% | -13.25% | -36.58% | -43.03% | -42.99% | -68.73% | -84.25% |
| Enovis ENOV | 1.69B Small-cap | 2.36% | 12.17% | -8.81% | -30.93% | -33.41% | -35.91% | -43.59% | -48.99% |
| Conmed CNMD | 1.69B Small-cap | 0.82% | 10.93% | -7.56% | -13.19% | -21.20% | -26.24% | -42.25% | -38.83% |
Ownership & Short Interest
Insider Ownership
10.74%
Institutional Ownership
104.58%
Shares Short
5M
Short Ratio
14.57
Short % of Shares Outstanding
24.14%
Average 10-Day Volume
634K
Average 90-Day Volume
411K
Establishment Labs Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Establishment Labs would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ESTA's 52-week high and low?
- In the last 52 weeks, Establishment Labs reached a high of $50.85 (on November 7, 2024) and a low of $26.56 (on April 9, 2025).
- What is the market cap and P/E ratio for ESTA?
- Curious about Establishment Labs's size and valuation? Its market capitalization stands at 1.09B. When it comes to valuation, the P/E ratio (trailing twelve months) is -12.57, and the forward P/E (looking ahead) is -22.85.
- Does ESTA pay dividends? If so, what's the yield?
- As for dividends, Establishment Labs isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Establishment Labs's main competitors or similar companies to consider before investing?
When looking at Establishment Labs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT229.31B Healthcare Medical Devices 17.14% 29.54% Boston Scientific
BSX153.73B Healthcare Medical Devices 32.89% 159.65% QuidelOrtho
QDEL1.78B Healthcare Medical Devices -42.99% -68.73% Enovis
ENOV1.69B Healthcare Medical Devices -35.91% -43.59% Conmed
CNMD1.69B Healthcare Medical Devices -26.24% -42.25% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Establishment Labs Holdings Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Establishment Labs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -261.18%, the Debt to Equity ratio from the most recent quarter is 993.34, and its Gross Profit Margin stands at 68.76%.
- What is the recent revenue and earnings growth for ESTA?
- Looking at Establishment Labs's growth, its revenue over the trailing twelve months (TTM) was $177M. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.30%, and quarterly earnings saw a YoY growth of 16.28%.
- How much of ESTA stock is held by insiders and institutions?
- Wondering who owns Establishment Labs stock? Company insiders (like executives and directors) hold about 10.74% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 104.58%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.